Cargando…
Cystinuria: An Overview of Diagnosis and Medical Management
Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Pediatrics Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317473/ https://www.ncbi.nlm.nih.gov/pubmed/35822468 http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105 |
_version_ | 1784755065411600384 |
---|---|
author | Sadiq, Sanober Cil, Onur |
author_facet | Sadiq, Sanober Cil, Onur |
author_sort | Sadiq, Sanober |
collection | PubMed |
description | Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid. |
format | Online Article Text |
id | pubmed-9317473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Turkish Pediatrics Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-93174732022-08-09 Cystinuria: An Overview of Diagnosis and Medical Management Sadiq, Sanober Cil, Onur Turk Arch Pediatr Review Cystinuria is a genetic disorder that causes recurrent nephrolithiasis. It is the most common type of monogenic stone disease accounting for 6%-8% of pediatric nephrolithiasis. Due to recurrent episodes of nephrolithiasis, it is associated with a very high prevalence of chronic kidney disease. Life-long medical treatment to reduce stone formation is critical in preventing chronic kidney disease and renal failure in cystinuria. In this article, we provide an overview of cystinuria with a special emphasis on medical treatment options including new agents such as alpha-lipoic acid. Turkish Pediatrics Association 2022-07-01 /pmc/articles/PMC9317473/ /pubmed/35822468 http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105 Text en © Copyright 2022 by The Turkish Archives of Pediatrics https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Review Sadiq, Sanober Cil, Onur Cystinuria: An Overview of Diagnosis and Medical Management |
title | Cystinuria: An Overview of Diagnosis and Medical Management |
title_full | Cystinuria: An Overview of Diagnosis and Medical Management |
title_fullStr | Cystinuria: An Overview of Diagnosis and Medical Management |
title_full_unstemmed | Cystinuria: An Overview of Diagnosis and Medical Management |
title_short | Cystinuria: An Overview of Diagnosis and Medical Management |
title_sort | cystinuria: an overview of diagnosis and medical management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317473/ https://www.ncbi.nlm.nih.gov/pubmed/35822468 http://dx.doi.org/10.5152/TurkArchPediatr.2022.22105 |
work_keys_str_mv | AT sadiqsanober cystinuriaanoverviewofdiagnosisandmedicalmanagement AT cilonur cystinuriaanoverviewofdiagnosisandmedicalmanagement |